ArticleFrontiers in medicine2025
Detachable coils and glue embolization for hemoptysis secondary to anomalous systemic arterial supply to the left lower lobe: a case report and literature review.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond the Usual Suspects: Rare Causes of Hemoptysis.Diagnostics (Basel, Switzerland) · 2026Review
- Endovascular coil embolization for anomalous systemic artery supply to the lower lateral segment of the left lung: a case report.Frontiers in medicine · 2026Article
- Tailored Management of Anomalous Systemic Arterial Supply to the Basal Segment of the Lung: A Case Report and Literature Review.Surgical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anomalous systemic arterial supply to the left lower lobe (ASALLL) is a rare congenital vascular malformation. It predominantly occurs in young and middle-aged adults, often presenting with recurrent hemoptysis of unknown etiology. The condition has a high clinical misdiagnosis rate, and its optimal treatment remains controversial. Traditional management involves surgical or thoracoscopic lobectomy with ligation of the anomalous artery. In recent years, with advancements in endovascular techniques, transcatheter arterial embolization (TAE) has gained increasing preference among patients due to its minimally invasive and highly effective nature. Previous cases have primarily employed coils or vascular plugs to occlude the anomalous artery, with no reported use of detachable coil combined with medical tissue glue for embolization. Here, we present the case of an 18-year-old male with hemoptysis, diagnosed with ASALLL via CTA, who underwent successful embolization of the anomalous systemic artery using detachable coils combined with medical tissue glue. The procedure was uneventful, with excellent postoperative recovery. At the 1-year follow-up, the patient remained asymptomatic, with no complications such as pulmonary necrosis or infection. We also reviewed recent literature on the diagnosis and management of this condition, discussing key points in its diagnosis and differential diagnosis, and comparing the advantages and disadvantages of surgical intervention versus TAE. It aims to provide more robust evidence for the accurate diagnosis and optimal treatment selection of this rare vascular anomaly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.